Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.NuMe Health, a developer of novel, evidence-based prebiotic products, has received $675,000 from BVM Capital under series A-1 financing round.
Subscribe to our email newsletter
The funds are expected to be used for product development and for commercializing the company’s prebiotic products for the dietary supplement and health food markets.
Prebiotics are non-digestible ingredients that serve as nutrients for beneficial GI bacteria.
Additionally, the company has also named Dean Stull as the new CEO.
Most recently, Stull worked as the founder and principal of Innovation Science, which provides consulting services for biotechnology, medical food and functional food companies.